Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Non-Current Liabilities (2016 - 2025)

Conmed (CNMD) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 2.26% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Dec 2025, down 2.26%, and an annual FY2025 reading of $1.2 billion, down 2.26% over the prior year.
  • Total Non-Current Liabilities was $1.2 billion for Q4 2025 at Conmed, down from $1.2 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.4 billion in Q2 2023 and bottomed at $937.6 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $1.2 billion, with a median of $1.3 billion recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 44.76% in 2023, then decreased 7.5% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $937.6 million in 2021, then skyrocketed by 43.81% to $1.3 billion in 2022, then dropped by 0.27% to $1.3 billion in 2023, then fell by 6.51% to $1.3 billion in 2024, then decreased by 2.26% to $1.2 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CNMD at $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.